• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2026 Dec;22(1):2638638.
doi: 10.1080/21645515.2026.2638638. Epub 2026 Mar 20.
Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study

Maria João Fonseca[SUP] 1 [/SUP], Stanislava Bratković[SUP] 2 [/SUP], Mikkel Pedersen[SUP] 3 [/SUP], Mathilde Kany[SUP] 3 [/SUP], Triantafyllos Pliakas[SUP] 4 5 [/SUP], Rachel Reeves[SUP] 6 [/SUP], Alen Marijam[SUP] 4 [/SUP], Elisa Turriani[SUP] 7 [/SUP], Nikoline Vestergaard Dich[SUP] 2 [/SUP], Yunus Çolak[SUP] 8 [/SUP], Marie Helleberg[SUP] 9 10 [/SUP]


Affiliations
Abstract

Respiratory syncytial virus (RSV) is, like influenza, one of the most common causes of severe acute respiratory infections (ARIs) in adults; however, its incidence across different risk and age groups is unknown. We estimated the incidence of registered ARIs in Danish adults, focusing on RSV and contextualizing with influenza. We conducted a nationwide cohort study in Denmark, including all adults aged ≥18 y with a registered ARI, during the 2011/12 to 2022/23 seasons. We estimated the incidence (per 100,000 person-years) of ARI overall and ARI attributable to RSV or influenza, overall and stratified by sex, age, and comorbidity. We identified 962,858 ARIs, of which 10,437 (1.1%) were attributed to RSV and 62,869 (6.5%) to influenza. The ARI incidence increased over time (range: 1,272-2,144), including a rise in RSV incidence (range: 0.2-91.6), while influenza incidence fluctuated (range: 6.7-322.0). In the 2022/23 season, RSV incidence was higher among females, older adults (198.7 in ≥60-y-olds, and 303.2 in ≥75-y-olds), and those with comorbidities, especially hematologic disease (868.6) and chronic obstructive pulmonary disease (679.5). Although influenza incidence was generally higher than RSV, the incidences were comparable for older adults and those with comorbidities. In conclusion, RSV is an important cause of ARIs among adults, comparable to influenza, particularly in older adults and those with comorbidities. These findings underscore the substantial burden of RSV that is relevant for public health planning and clinical decision-making, particularly given the recent approval of three highly effective RSV vaccines.

Keywords: Acute respiratory infection; RSV; disease burden; incidence; influenza; respiratory syncytial virus; vaccination.

 
Back
Top